Literature DB >> 30342699

Trends in catheter-directed thrombolysis and systemic thrombolysis for the treatment of pulmonary embolism.

Srinath Adusumalli1, Bram J Geller2, Lin Yang3, Jay Giri4, Peter W Groeneveld3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30342699      PMCID： PMC6446931          DOI： 10.1016/j.ahj.2018.09.013

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  6 in total

1.  Pulmonary embolism as a cause of death in patients with heart disease: an autopsy study.

Authors:  Tomás Pulido; Alberto Aranda; Marco Antonio Zevallos; Edgar Bautista; Maria Luisa Martínez-Guerra; Luis Efrén Santos; Julio Sandoval
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

2.  2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

Authors:  Stavros V Konstantinides; Adam Torbicki; Giancarlo Agnelli; Nicolas Danchin; David Fitzmaurice; Nazzareno Galiè; J Simon R Gibbs; Menno V Huisman; Marc Humbert; Nils Kucher; Irene Lang; Mareike Lankeit; John Lekakis; Christoph Maack; Eckhard Mayer; Nicolas Meneveau; Arnaud Perrier; Piotr Pruszczyk; Lars H Rasmussen; Thomas H Schindler; Pavel Svitil; Anton Vonk Noordegraaf; Jose Luis Zamorano; Maurizio Zompatori
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

3.  Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.

Authors:  Stavros V Konstantinides; Eric Vicaut; Thierry Danays; Cecilia Becattini; Laurent Bertoletti; Jan Beyer-Westendorf; Helene Bouvaist; Francis Couturaud; Claudia Dellas; Daniel Duerschmied; Klaus Empen; Emile Ferrari; Nazzareno Galiè; David Jiménez; Maciej Kostrubiec; Matija Kozak; Christian Kupatt; Irene M Lang; Mareike Lankeit; Nicolas Meneveau; Massimiliano Palazzini; Piotr Pruszczyk; Matteo Rugolotto; Aldo Salvi; Olivier Sanchez; Sebastian Schellong; Bozena Sobkowicz; Guy Meyer
Journal:  J Am Coll Cardiol       Date:  2017-03-28       Impact factor: 24.094

4.  Submassive pulmonary embolism.

Authors:  Gregory Piazza
Journal:  JAMA       Date:  2013-01-09       Impact factor: 56.272

5.  Fibrinolysis for patients with intermediate-risk pulmonary embolism.

Authors:  Guy Meyer; Eric Vicaut; Thierry Danays; Giancarlo Agnelli; Cecilia Becattini; Jan Beyer-Westendorf; Erich Bluhmki; Helene Bouvaist; Benjamin Brenner; Francis Couturaud; Claudia Dellas; Klaus Empen; Ana Franca; Nazzareno Galiè; Annette Geibel; Samuel Z Goldhaber; David Jimenez; Matija Kozak; Christian Kupatt; Nils Kucher; Irene M Lang; Mareike Lankeit; Nicolas Meneveau; Gerard Pacouret; Massimiliano Palazzini; Antoniu Petris; Piotr Pruszczyk; Matteo Rugolotto; Aldo Salvi; Sebastian Schellong; Mustapha Sebbane; Bozena Sobkowicz; Branislav S Stefanovic; Holger Thiele; Adam Torbicki; Franck Verschuren; Stavros V Konstantinides
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

Review 6.  Pulmonary embolism and deep vein thrombosis.

Authors:  Samuel Z Goldhaber; Henri Bounameaux
Journal:  Lancet       Date:  2012-04-10       Impact factor: 79.321
  6 in total
  3 in total

1.  Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis.

Authors:  Ariel Izcovich; Juan M Criniti; Federico Popoff; Liming Lu; Jiaming Wu; Walter Ageno; Daniel M Witt; Michael R Jaff; Sam Schulman; Veena Manja; Peter Verhamme; Gabriel Rada; Yuqing Zhang; Robby Nieuwlaat; Wojtek Wiercioch; Holger J Schünemann; Ignacio Neumann
Journal:  Blood Adv       Date:  2020-04-14

2.  Rationale for catheter-based therapies in acute pulmonary embolism.

Authors:  M A de Winter; G J Vlachojannis; D Ruigrok; M Nijkeuter; A O Kraaijeveld
Journal:  Eur Heart J Suppl       Date:  2019-11-21       Impact factor: 1.803

3.  Feasibility and safety of catheter-directed thrombolysis via superficial cubital vein for the treatment of acute massive and submassive pulmonary embolism.

Authors:  Lovel Giunio; Mislav Lozo; Josip Andelo Borovac; Anteo Bradaric; Jaksa Zanchi; Dino Miric
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-12-29       Impact factor: 1.426
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.